高级搜索
杨晖, 周丽, 刘标, 钱军. 阿帕替尼治疗合并有KDR基因突变的晚期肾上腺皮质癌获长期缓解1例报道[J]. 肿瘤防治研究, 2019, 46(1): 99-102. DOI: 10.3971/j.issn.1000-8578.2019.18.0400
引用本文: 杨晖, 周丽, 刘标, 钱军. 阿帕替尼治疗合并有KDR基因突变的晚期肾上腺皮质癌获长期缓解1例报道[J]. 肿瘤防治研究, 2019, 46(1): 99-102. DOI: 10.3971/j.issn.1000-8578.2019.18.0400
YANG Hui, ZHOU Li, LIU Biao, QIAN Jun. Long-term Remission of Advanced Adrenocortical Carcinoma with KDR Gene Mutation Treated with Apatinib Mesylate: A Case Report[J]. Cancer Research on Prevention and Treatment, 2019, 46(1): 99-102. DOI: 10.3971/j.issn.1000-8578.2019.18.0400
Citation: YANG Hui, ZHOU Li, LIU Biao, QIAN Jun. Long-term Remission of Advanced Adrenocortical Carcinoma with KDR Gene Mutation Treated with Apatinib Mesylate: A Case Report[J]. Cancer Research on Prevention and Treatment, 2019, 46(1): 99-102. DOI: 10.3971/j.issn.1000-8578.2019.18.0400

阿帕替尼治疗合并有KDR基因突变的晚期肾上腺皮质癌获长期缓解1例报道

Long-term Remission of Advanced Adrenocortical Carcinoma with KDR Gene Mutation Treated with Apatinib Mesylate: A Case Report

/

返回文章
返回